首页> European journal of haematology> Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.

Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hareth,Nahi

第一单位： Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

作者： Hareth,Nahi ^[1] ; Thea Kristin,Våtsveen ^[2] ; Johan,Lund ^[1] ; Bart M S,Heeg ^[3] ; Birgitte,Preiss ^[4] ; Evren,Alici ^[1] ; Michael Boe,Møller ^[4] ; Karin Fahl,Wader ^[5] ; Hanne E H,Møller ^[4] ; Lill Anny,Grøseth ^[6] ; Brian,Østergaard ^[7] ; Hong Yan,Dai ^[8] ; Erik,Holmberg ^[9] ; Gösta,Gahrton ^[1] ; Anders,Waage ^[6] ; Niels,Abildgaard ^[7]

作者单位： Department of Medicine, Karolinska Institutet, Stockholm, Sweden. ^[1] KG Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.;Department of Pathology, St Olavs Hospital, Trondheim, Norway. ^[2] PharmacoEpidemiology & PharmacoEconomics (PE2), University of Groningen, Groningen, The Netherlands.;Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands. ^[3] Department of Pathology, Odense University Hospital, Odense, Denmark. ^[4] KG Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.;Department of Oncology, St Olavs Hospital, Trondheim, Norway. ^[5] KG Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.;Department of Hematology, St Olavs Hospital, Trondheim, Norway. ^[6] Department of Hematology, Odense University Hospital, Odense, Denmark. ^[7] Department of Pathology, St Olavs Hospital, Trondheim, Norway. ^[8] Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. ^[9]

关键词 chromosomal abberation clinical gain 1q21 multiple myeloma